# Council Regulation (EC) No 1176/2008 of 27 November 2008 amending Council Regulation (EC) No 713/2005 imposing a definitive countervailing duty on imports of certain broad spectrum antibiotics originating in India, Article 1

Extent: E+W+S+N.I.

Paragraph 2 of Article 1 of Regulation (EC) No 713/2005 shall be replaced by the following:
‘2. The rate of duty applicable to the net free-at-Community-frontier price, before duty for imports produced in India by the companies listed below, shall be as follows:
17,3 % for KDL Biotech Ltd, Mumbai (TARIC additional code: A580),
28,1 % for Nectar Lifesciences Ltd, Chandigarh (TARIC additional code: A581),
25,3 % for Nestor Pharmaceuticals Ltd, New Delhi (TARIC additional code: A582),
11,9 % for Ranbaxy Laboratories Ltd, New Delhi (TARIC additional code: 8221),
28,1 % for Torrent Gujarat Biotech Ltd, Ahmedabad (TARIC additional code: A583),
28,1 % for Surya Pharmaceuticals Ltd, Chandigarh (TARIC additional code: A584),
32 % for all other companies (TARIC additional code: 8900).’

---
Source: https://www.legislation.gov.uk/eur/2008/1176/article/1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2008-1176/article-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.